MAPK3 c.442T>C ;(p.Y148H)

Variant ID: 16-30129771-A-G

NM_002746.2(MAPK3):c.442T>C;(p.Y148H)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.

Nature Communications
Daniels, Jay J; Doukas, Peter G PG; Escala, Maria E Martinez MEM; Ringbloom, Kimberly G KG; Shih, David J H DJH; Yang, Jingyi J; Tegtmeyer, Kyle K; Park, Joonhee J; Thomas, Jane J JJ; Selli, Mehmet E ME; Altunbulakli, Can C; Gowthaman, Ragul R; Mo, Samuel H SH; Jothishankar, Balaji B; Pease, David R DR; Pro, Barbara B; Abdulla, Farah R FR; Shea, Christopher C; Sahni, Nidhi N; Gru, Alejandro A AA; Pierce, Brian G BG; Louissaint, Abner A; Guitart, Joan J; Choi, Jaehyuk J
Publication Date: 2020-04-14

Variant appearance in text: MAPK3: Y148H
PubMed Link: 32286303
Variant Present in the following documents:
  • 41467_2020_15572_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Cells
Smorodinsky-Atias, Karina K; Soudah, Nadine N; Engelberg, David D
Publication Date: 2020-01-06

Variant appearance in text: ERK1: Y148H
PubMed Link: 31935908
Variant Present in the following documents:
  • Main text
  • cells-09-00129.pdf
View BVdb publication page



ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.

Cancer Research
Goetz, Eva M EM; Ghandi, Mahmoud M; Treacy, Daniel J DJ; Wagle, Nikhil N; Garraway, Levi A LA
Publication Date: 2014-12-01

Variant appearance in text: ERK1: Y148H
PubMed Link: 25320010
Variant Present in the following documents:
  • Main text
View BVdb publication page